WAT

Waters Corporation · Healthcare · Medical - Diagnostics & Research
$330.98
+6.30 (+1.94%)
Mkt Cap: 19.70B
Key Metrics
MetricValue
P/E RatioN/A
EV/EBITDAN/A
ROEN/A
Gross MarginN/A
Revenue GrowthN/A
FCF Yield2.4%
Dividend YieldN/A
Market Cap19.70B
Volume526.9K
Recent News
Waters Debuts Industry-First Extended-Range MALS Detector for UHPLC/UPLC, Powering Rapid Characterization of Large Molecules
prnewswire.com · 2026-04-14
Brown Lisle Cummings Inc. Increases Holdings in Waters Corporation $WAT
defenseworld.net · 2026-04-12
Waters Stock Shoots Higher As FDA Clears At-Home Cervical Cancer Screening Kit
benzinga.com · 2026-04-08
Waters Announces FDA Clearance of the Most Comprehensive At-Home Cervical Cancer Screening Tool, the Onclarity HPV Self-Collection Kit and FDA-Approved HPV Assay
prnewswire.com · 2026-04-08
ClearBridge Dividend Strategy Q1 2026 Portfolio Positioning
seekingalpha.com · 2026-04-08
Aberdeen Group plc Cuts Stock Position in Waters Corporation $WAT
defenseworld.net · 2026-04-06

Unlock the Full Deep Scan

9 AI agents analyze WAT across earnings, insider flow, macro conditions, corporate strategy, market microstructure, and price action.

Sign Up Free →